# Anti CD19 Gene Therapy for B-cell Lymphoma

> **NCT07211048** · NA · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 18 (estimated)

## Conditions studied

- B-cell Lymphoma

## Interventions

- **DRUG:** Anti-CD19 gene injection

## Key facts

- **NCT ID:** NCT07211048
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-20
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211048, "Anti CD19 Gene Therapy for B-cell Lymphoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07211048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*